Next-generation sequencing is among the fastest-growing markets in the life science instrument market, with 2009 instrument demand estimated to increase more than 40%. The advent of next-generation sequencing has birthed the need for novel approaches to sample preparation (for the purpose of this article, sample preparation encompasses purification, fragmentation, target capture and enrichment prior to […]
The life science instrument market includes 10 product categories and accounts for the largest share of the analytical instrumentation market due to strong support from government programs, and private and public research institutions. Somewhat immune to negative sales trends caused by the downturn of global economies, the life science market grew 7.2% in 2008 to […]
New Orleans, Louisiana, played host to the 59th annual Pittsburgh conference and exhibition (Pittcon), which was held March 1–7 at the Ernest N. Morial Convention Center. Although Pittcon took place against a backdrop of escalating fears of a US recession, one would have never known it. Companies were upbeat about future business prospects and the […]
Next-generation DNA sequencers have advanced genomic research through more accurate, less costly and faster analyses, and enabled the development of novel applications. The technology will now be applied to a coordinated international effort to better understand the extent of human genetic variation and its relation to disease. The National Institutes of Health’s 1000 Genomes Project […]
The life science instrumentation market grew 8.7% to $9.2 billion in 2007. The market consists of DNA and peptide sequencers, DNA and peptide synthesizers, nucleic acid amplification or polymerase chain reaction (PCR) systems, gel electrophoresis equipment, molecular biology purification kits, microarray-based products, biosensors, bioinformatics and cheminformatics, cell analysis technologies and in vivo animal imaging. The […]
Agilent’s ambitions continue to grow. After a successful 2006 (see IBO 1/15/07), which saw it enter the high-end mass spectrometry (MS) market, the company has set its sights on other market segments. In late March, Agilent announced the formation of a Materials Sciences Solutions Unit (MSSU) within its Life Science and Chemical Analysis (LSCA) business […]
Basel, Switzerland 3/29/07; Branford, CT 3/29/07—Roche has signed a definitive agreement to purchase 454 Life Sciences from CuraGen for $140 million in cash and up to $14.9 million in cash upon the exercise of stock options and warrants. Roche has exclusively distributed 454’s DNA sequencing systems since May 2005. In 2006, 454’s product revenue grew […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
